Spark Therapeutics Inc. (Nasdaq: ONCE) reported upbeat data from a Phase 3 trial of SPK-RPE65 sending the stock price soaring $9.23 to $53.16.
Spark Therapeutics reports upbeat data
October 05, 2015 at 14:17 PM EDT
Spark Therapeutics reports upbeat dataOctober 05, 2015 at 14:17 PM EDT
Spark Therapeutics Inc. (Nasdaq: ONCE) reported upbeat data from a Phase 3 trial of SPK-RPE65 sending the stock price soaring $9.23 to $53.16.
Related Stocks:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|